GlymaxX® - ADCC Enhancement Technology
. GlymaxX® GlymaxX® is a technology to permanently modify animal cells to produce afucosylated antibodies/proteins (ha…
. GlymaxX® GlymaxX® is a technology to permanently modify animal cells to produce afucosylated antibodies/proteins (ha…
Glioblastoma multiforme (GBM) is the most severe form of brain cancer and progresses rapidly. With the first-line treatm…
Wissenschaftler des Max-Delbrück-Centrums für Molekulare Medizin (MDC) Berlin-Buch und der Charité - Universitätsmedizin…
Natural killer (NK) cells have been implicated in the recognition and annihilation of tumor cells. As demonstrated in a…
Die Micromet AG gibt neue Ergebnisse zum Wirkprinzip von BiTE™-Medikamenten, einer neuen Klasse von Antikörper-Derivaten…